Your browser doesn't support javascript.
loading
Cardiotoxicity of pyrethroids: molecular mechanisms and therapeutic options for acute and long-term toxicity.
Marques, Leisiane P; Joviano-Santos, Julliane V; Souza, Diego S; Santos-Miranda, A; Roman-Campos, D.
Afiliación
  • Marques LP; Laboratory of CardioBiology, Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Joviano-Santos JV; Laboratory of CardioBiology, Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Souza DS; Center for Mathematics, Computing, and Cognition (CMCC), Federal University of ABC, UFABC, São Bernardo do Campo, São Paulo, SP, Brazil.
  • Santos-Miranda A; Laboratory of CardioBiology, Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Roman-Campos D; Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Biochem Soc Trans ; 50(6): 1737-1751, 2022 12 16.
Article en En | MEDLINE | ID: mdl-36383062
ABSTRACT
Pyrethroids (PY) are synthetic pesticides used in many applications ranging from large-scale agriculture to household maintenance. Their classical mechanisms of action are associated with binding to the sodium channel of insect neurons, disrupting its inactivation, ensuring their use as insecticides. However, PY can also lead to toxicity in vertebrates, including humans. In most toxicological studies, the impact of PY on heart function is neglected. Acute exposure to a high dose of PY causes enhancement of the late sodium current (INaL), which impairs the action potential waveform and can cause severe cardiac arrhythmias. Moreover, long-term, low-dose exposure to PY displays oxidative stress in the heart, which could induce tissue remodeling and impairment. Isolated and preliminary evidence supports that, for acute exposure to PY, an antiarrhythmic therapy with ranolazine (an INaL blocker), can be a promising therapeutic approach. Besides, heart tissue remodeling associated with low doses and long-term exposure to PY seems to benefit from antioxidant therapy. Despite significant leaps in understanding the mechanical details of PY intoxication, currently, few studies are focusing on the heart. In this review, we present what is known and what are the gaps in the field of cardiotoxicity induced by PY.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piretrinas / Cardiotoxicidad Límite: Animals / Humans Idioma: En Revista: Biochem Soc Trans Año: 2022 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piretrinas / Cardiotoxicidad Límite: Animals / Humans Idioma: En Revista: Biochem Soc Trans Año: 2022 Tipo del documento: Article País de afiliación: Brasil